BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35546301)

  • 1. Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc.
    Garcia-Cuellar MP; Prinz A; Slany RK
    Haematologica; 2022 Nov; 107(11):2601-2616. PubMed ID: 35546301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
    Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
    Wang GG; Pasillas MP; Kamps MP
    Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation.
    Morgado E; Albouhair S; Lavau C
    Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.
    Mohr S; Doebele C; Comoglio F; Berg T; Beck J; Bohnenberger H; Alexe G; Corso J; Ströbel P; Wachter A; Beissbarth T; Schnütgen F; Cremer A; Haetscher N; Göllner S; Rouhi A; Palmqvist L; Rieger MA; Schroeder T; Bönig H; Müller-Tidow C; Kuchenbauer F; Schütz E; Green AR; Urlaub H; Stegmaier K; Humphries RK; Serve H; Oellerich T
    Cancer Cell; 2017 Apr; 31(4):549-562.e11. PubMed ID: 28399410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
    Wang GG; Pasillas MP; Kamps MP
    Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias.
    Lawrence HJ; Rozenfeld S; Cruz C; Matsukuma K; Kwong A; Kömüves L; Buchberg AM; Largman C
    Leukemia; 1999 Dec; 13(12):1993-9. PubMed ID: 10602420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
    Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
    Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
    Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis.
    Collins C; Wang J; Miao H; Bronstein J; Nawer H; Xu T; Figueroa M; Muntean AG; Hess JL
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9899-904. PubMed ID: 24958854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
    Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
    Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deficiency of tumor suppressor prep1 accelerates the onset of meis1- hoxa9 leukemogenesis.
    Dardaei L; Modica L; Iotti G; Blasi F
    PLoS One; 2014; 9(5):e96711. PubMed ID: 24809472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis.
    Hu YL; Fong S; Ferrell C; Largman C; Shen WF
    Mol Cell Biol; 2009 Sep; 29(18):5181-92. PubMed ID: 19620287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
    Argiropoulos B; Yung E; Xiang P; Lo CY; Kuchenbauer F; Palmqvist L; Reindl C; Heuser M; Sekulovic S; Rosten P; Muranyi A; Goh SL; Featherstone M; Humphries RK
    Blood; 2010 May; 115(20):4071-82. PubMed ID: 20237320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEIS1 and HOXA7 genes in human acute myeloid leukemia.
    Afonja O; Smith JE; Cheng DM; Goldenberg AS; Amorosi E; Shimamoto T; Nakamura S; Ohyashiki K; Ohyashiki J; Toyama K; Takeshita K
    Leuk Res; 2000 Oct; 24(10):849-55. PubMed ID: 10996203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.
    Schneider E; Staffas A; Röhner L; Malmberg ED; Ashouri A; Krowiorz K; Pochert N; Miller C; Wei SY; Arabanian L; Buske C; Döhner H; Bullinger L; Fogelstrand L; Heuser M; Döhner K; Xiang P; Ruschmann J; Petriv OI; Heravi-Moussavi A; Hansen CL; Hirst M; Humphries RK; Rouhi A; Palmqvist L; Kuchenbauer F
    Haematologica; 2018 Feb; 103(2):246-255. PubMed ID: 29217774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines.
    Wermuth PJ; Buchberg AM
    Blood; 2005 Feb; 105(3):1222-30. PubMed ID: 15479723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
    Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.